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Fig. 2: Number of abnormal karyotypes obtained from 154 analysed bone marrow samples vs peripheral cytopenias.
1. Introduction
The hemogram is the most requested study and an essential tool in the diagnosis of different pathologies in pediatric age, especially in hematological diseases.
Peripheral cytopenias are the first laboratory finding suggestive of a hematological disease, such as myelodysplastic syndrome, idiopathic thrombocytopenic purpura, among others.
Confirmation of these pathologies should include the study of bone marrow, with analysis of this by different methodologies, including conventional cytogenetic karyotype analysis.
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2. Objective
In this work, we intend to present and establish a correlation between the results obtained
by conventional cytogenetics in bone marrow samples and observation of peripheral
cytopenias in a paediatric population over 22 years.
3. Methods
A retrospective 22-year series (1995-2017) of 154 bone marrow samples from a paediatric
population was analysed, which at the initial diagnosis presented peripheral cytopenia. The
samples were process according to the established protocol for chromosome analysis in
bone marrow, including cell culture, for each biological product, followed by a cytogenetic
study to identify the karyotype.
5. Conclusion
In this population, most samples with cytopenia/(s) have a normal karyotype,
suggesting that they may not result from a malignant haematological disease, but
from a transient situation resulting from a viral or bacterial infection, or the genetic
alteration responsible for the disease, is not observed by classical cytogenetics.
Peripheral cytopenias are extremely important for the suspicion of pediatric
hematological diseases, especially in the myelodysplastic syndrome.
The analysis of the bone marrow by conventional cytogenetics plays a
fundamental role in the diagnosis and confirmation of these pathologies, in the
clinical and prognostic evolution of the same, allowing the establishment of risk
groups, which allows the choice of an appropriate therapy.
However, micro-arrays should be performed with the aim of identifying micro-
deletions / duplications or loss of heterozygosity that are characteristic in this
group of pathologies.
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4. Results
 In the 154 cytopenias analysed, it was verified (Fig. 1):
 The mean age at diagnosis = 7 years and 6 months
 53% of sex F and 47% of sex M
 33 pancytopenia (21,4%),
 31 bicytopenias (20,1%),
 21 neutropenia (13,6%),
 11 anemias (7,1%) and
 58 thrombocytopenia (37,7%) [22 (14,3%) of idiopathic origin].
 In the 154 samples analysed with peripheral cytopenias, 15 samples with
abnormal karyotype were identified (Fig. 2 and Table 1), some of which
presented a complex karyotype.
 Most samples with abnormal karyotypes had pancytopenia or bicytopenia (Fig.
2 and Table 1).
Fig. 1: Distribution of samples according to the different cytopenias diagnosed.
Cytop. Sample Abnormal Karyotype Diagnostic Hypothesis
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I 46,XY,t(15;17)(q22;q21)[29]/46,XY[1]
Acute Promyelocytic Leukemia 
(PML/RARA)1;2
II
43~45,XX,der(5;17)(p10;q10),-6, 
der(7)t(2;7)(q13;p22)[cp30]
Myeloid Neoplasms [(MDS (?) vs 
AML (?)]3
III
46,XY,del(4)(q21)[2]/46,XY,del(7)(q22)[2]/46,XY,del(
7)(q11.2)[2]/46,XY,der(7)(del(p15)del(7)(q22)[2]/46,X
Y,del(2)(p11),del(7)(q11.2)[3]/46,XY[19]
MDS(?)2,8 and AML  (?)2,8 ou decifit 
of B12 vitamin and folic acid(?)4
IV 47,XX,+8[20]/46,XX[10] MDS(?) vs AML (?)2,5
V 46,XX,del(5)(q15q31),t(15;17)(q22;q21)[21]/46,XX[9]
Acute Promyelocytic Leukemia 
(PML/RARA)1;2
VI 47,XXY[15]/46,XY[35]
↑risk of systemic lupus 
erythematosus (?)6,7
B
ic
y
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p
e
n
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s
VII
49,XY,ins(1;7)(p32;q22p11),r(7),+19,+21,+22[5]/50,i
dem,+Y[39]/50,idem, +Y,t(6;16)(q23;q22)[4]/46,XY[2] MDS(?) vs AML (?)
9,10,11
VIII 46,XX/tetraploidy/octoploidy Megakaryocytic Leukemia(?)12
IX 47,XY,+21c[30]
Down Syndrome→ autoimmune 
diseases (immunodeficiency)13
X 47,XY,i(18)(p10)c[30] Infection (?)
XI 46,XY,del(10)(p11.1p11.2)[7]/46,XY[23]
Congenital Monoblastic Leukemia 
(?)14
XII
47,XY,+mar[19].ish 
der(22)(wcp22+,D14Z1/D22Z1+)/46,XY[11] MDS(?) 
PTI XIII 47,XY,+21c[30]
Down Syndrome→ autoimmune 
diseases (immunodeficiency)13
Tromb. XIV Hipodiploidia ALL(?) 15
Anemia XV 47,XY,+21c[30]
Down Syndrome→medullar 
insufficiency or anemia after 
infectious intercurrence.13
Tab. 1: Abnormal karyotypes obtained from the 154 bone marrow samples analysed.
